Nutrition
Volume 26, Issue 4 , Pages 382-389 , April 2010

Visceral adipose tissue and body fat mass: Predictive values for and role of gender in cardiometabolic risk among Turks

  • Altan Onat, M.D.

      Affiliations

    • Turkish Society of Cardiology, Istanbul, Turkey
    • Department of Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-212-351-6217; fax: +90-212-351-4235.
    • ,
  • Murat Uğur, M.D.

      Affiliations

    • Siyami Ersek Center for Cardiovascular Surgery, Istanbul, Turkey
    • ,
  • Günay Can, M.D.

      Affiliations

    • Department of Public Health, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Hüsniye Yüksel, M.D.

      Affiliations

    • Department of Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Gülay Hergenç, Ph.D.

      Affiliations

    • Biology Department, Yildiz Technical University, Istanbul, Turkey

Received 16 February 2009 ,Accepted 18 May 2009.

References 

  1. Després J-P, Brewer HB. Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance. Eur Heart J. 2008;10(suppl B):B1–B3
  2. Vega GL, Adams-Huet B, Peshock R, Willett DW, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab. 2006;91:4459–4466
  3. Després J-P, Poirier P, Bergeron J, Tremblay A, Lemieux I, Alméras N. From individual risk factors and the metabolic syndrome to global cardiometabolic risk. Eur Heart J. 2008;10(suppl B):B24–B33
  4. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new world-wide definition. Lancet. 2005;366:1059–1062
  5. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity. 2006;14(suppl 1):20S–4
  6. Ferrannini E, Sironi AM, Iozzo P, Gastaldelli A. Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk. Eur Heart J. 2008;10(suppl B):B4–10
  7. Onat A, Ceyhan K, Basar Ö Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285–292
  8. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001;156:1–10
  9. Onat A, Avcı GŞ, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004;28:1018–1025
  10. Ferland M, Déspres JP, Tremblay A, Pineault S, Nadeau A, Moorjani S, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr. 1989;61:139–148
  11. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:3160–3167
  12. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  13. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438
  14. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis. 2007;191:182–190
  15. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab. 2001;86:5457–5464
  16. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed.. Geneva: World Health Organization; 1982;p. 124–7
  17. Demerath FW, Sun SS, Rogers N, Lee M, Reed D, Choh AC, et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity. 2007;15:2984–2993
  18. Després J-P, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20:1932–1938
  19. Hallgreen CE, Hall KD. Allometric relationship between changes of visceral fat and total fat mass. Int J Obes Relat Metab Disord. 2008;32:845–852
  20. Drolet R, Richard C, Sniderman AD, Maillout J, Fortier M, Huot C, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes. 2008;32:283–291
  21. Cartier A, Lemieux I, Alméras N, Tremblay A, Bergeron J, Després JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab. 2008;93:1931–1938
  22. de Luis DA, Gonzales Sagradeo M, Conde R, Aller R, Izaola O, Romero E. Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure. Ann Nutr Metab. 2007;51:416–420
  23. Goodpaster BH, Krishnaswami S, Haris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, et al. Obesity, regional body fat distribution and the metabolic syndrome in older men and women. Arch Intern Med. 2005;165:777–783
  24. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CDA, Yudkin JS, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn Study. Diabetes Care. 2004;37:372–377
  25. Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, et al. Health, Aging and Body Composition Study. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol. 2004;160:741–749
  26. Onat A, Hergenç G, Türkmen S, Yazıcı M, Sarı İ, Can G. Discordance between Insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism. 2006;55:445–452
  27. Onat A, Can G, Ayhan E, Kaya Z, Hergenç G. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Metabolism. 2009;
  28. Onat A, Sarı İ, Hergenç G, Yazıcı M, Can G, Uyarel H, et al. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. Metabolism. 2007;56:348–356
  29. Onat A, Hergenç G, Keleş İ, Doğan Y, Türkmen S, Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome: prospective study of a cohort with normal glucose metabolism. Metabolism. 2005;54:800–808

 The Turkish Adult Risk Factor survey 2006–2008 was supported by the Turkish Society of Cardiology and the pharmaceutical companies SanofiAventis, Pfizer, Novartis, and AstraZeneca, Istanbul, Turkey.

PII: S0899-9007(09)00240-8

doi: 10.1016/j.nut.2009.05.019

Nutrition
Volume 26, Issue 4 , Pages 382-389 , April 2010

Article Tools

* Image Usage & Resolution